City

Hangzhou (1)

Paris (1)

Utrecht (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

Sponsor

French Africa Pediatric Oncology Group (1)

IRCCS San Raffaele (1)

UMC Utrecht (1)

Zhejiang University (1)

Collaborator

Federatie Medisch Specialisten (1)

Gustave Roussy, Cancer Campus, Grand Paris (1)

Nederlandse Vereniging voor Heelkunde (1)

Patientfederatie Nederland (1)

ZonMw: The Netherlands Organisation for Health Research and Development (1)

Zorgverzekeraars Nederland (1)

Intervention

18f-fapi (1)

18f-fdg (1)

observational (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (4)

Study Type

Observational (2)

Interventional (1)

Observational [Patient Registry] (1)

staging

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

Completed

18F-FAPI
+4 more

Hangzhou, Zhejiang, China

the First Affiliated Hospital, School of Medicine, Zhejiang Univ

May 31, 2023

Thereapeutic Recommendantion for a Hodgkin Lymphoma

Not yet recruiting

Staging
Therapeutic Recommendations

Observational

Paris, France

Brenda Mallon

Sep 20, 2022

Gastric Cancer, Staging, FDG-PET/CT Trial in Utrecht

Active, not recruiting

Gastric Cancer
+3 more

Utrecht, Netherlands

University Medical Center Utrecht

Apr 29, 2021

Prognostic Factors in Patients Submitted to Surgical Treatment

Completed

Thymoma
+4 more

(no location specified)

Oct 5, 2020